Bristol-Myers Squibb (BMY.US) climbs pre-market! Two experimental drugs achieve success in phase III clinical trials, accelerating pipeline diversification

智通财经2026/10/12 12:36

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

It is reported by Zhitong Finance APP that Bristol-Myers Squibb (BMY.US) has achieved success in phase III clinical trials for two experimental drugs intended to treat a rare endocrine cancer and a fatal lung disease, giving a boost to the pharmaceutical company’s new product pipeline. Encouraged by this news, as of press time, Bristol-Myers Squibb’s US shares rose nearly 4% in pre-market trading on Monday.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bristol-Myers Squibb (BMY.US) climbs pre-market! Two experimental drugs achieve success in phase III clinical trials, accelerating pipeline diversification

You may also like

Crypto prices